Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department (RDOcularUS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03106025|
Recruitment Status : Unknown
Verified January 2018 by Loma Linda University.
Recruitment status was: Not yet recruiting
First Posted : April 10, 2017
Last Update Posted : January 31, 2018
|Condition or disease||Intervention/treatment||Phase|
|Retinal Detachment||Device: Ultrasound||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Masking Description:||ophthalmologists will be blinded to the ultrasound result and formal ophthalmology assessment will be compared to the ultrasound assessment.|
|Official Title:||Use of Ocular Point of Care Ultrasound in Diagnosing Retinal Detachment in the Emergency Department: A Prospective Study.|
|Estimated Study Start Date :||March 2018|
|Estimated Primary Completion Date :||May 2019|
|Estimated Study Completion Date :||May 2019|
Experimental: Patients Receiving Ultrasound
Enrolled participants will receive a bedside ocular ultrasound of the affected eye and the ultrasound will be compared with the ophthalmologist diagnosis. The participant's medical record will also be reviewed for information regarding demographics, complications, and outcomes.
Each participant will receive an ocular ultrasound which poses minimal to no harm to the participant and the ultrasound results compared to final diagnosis.
- Ocular Ultrasound [ Time Frame: 10 minutes during the patient's visit will be towards obtaining consent and ultrasound evaluation ]Ocular ultrasound diagnosis will be compared to formal ophthalmology evaluation diagnosis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03106025
|Contact: Tze Lyn S Tseeng, MDemail@example.com|
|Contact: Ellen Reibling, PhD||909.558.7407 ext 87407||EReibling@llu.edu|
|Principal Investigator:||Tze Lyn S Tseeng, MD||Loma Linda University|